The chemical structure is similar to testosterone propionate. White crystalline powder. Practically insoluble in water, soluble in ethyl alcohol, slowly soluble in vegetable oils.
It has an androgenic (less pronounced than testosterone propionate) and an anabolic (more pronounced than testosterone propionate) effect. It has an antitumor effect in thymus cancer, including in the presence of metastases, as well as in patients whose ovarian function is suppressed by radiation, androgen drugs or who have undergone an ovariectomy. It is more effective in bilateral ovariectomy.
Breast cancer, including those with metastases, in women with a preserved menstrual cycle or with menopause up to 5 years.
Hypersensitivity, acute diseases of the liver, kidneys, cardiovascular system (myocardial infarction, severe hypertension, hypertensive crisis), hypercalcemia, end-stage breast cancer.
Acute parenchymal hepatitis, jaundice, hypercalcemia, hypercalciuria, cardiac dysfunction, virilization.
Method of administration and dosage
In / m, during active metastasis, 100 mg/day, during remission — 50 mg / day daily. The treatment is long-term.
With the development of side effects, the administration of drostanolone should be temporarily suspended.
|Active ingredient, mg||100|
|1 bottle, ml||10|
|Bottles in the package, pcs||1|